Reduced E-cadherin expression and enlargement of cancer nuclei strongly correlate with hematogenic metastasis in colorectal adenocarcinoma

作者: M. Ikeguchi, T. Taniguchi, M. Makin

DOI: 10.1080/003655200750023219

关键词: Cancer researchCancer cellCancerSurvival rateAdenocarcinomaMetastasisColorectal cancerMedicinePathologyImmunohistochemistryHepatocellular carcinoma

摘要: BACKGROUND: Synchronous and metachronous hematogenic metastases are frequently detected in patients with colorectal carcinoma. Once these have developed, the prognoses of poor. Previously, we reported that enlargement cancer nuclei significantly correlated metastatic potential gastric hepatocellular Moreover, recently it has been reduced expression E-cadherin is associated tumor metastasis. To evaluate correlation between nuclear area (NA) cells E-cadherin, to elucidate whether factors correlate clinical outcome carcinoma, 105 consecutive were investigated. METHODS: In each case, NAs 600 analyzed by means a computer-assisted image analysis system was immunohistochemically an anti-E-cadherin monoclonal antibody. The levels divided into three groups according percentages E-cadherin-positive (level 0: positive 80%). RESULTS: mean NA tumors 57 microm2. enlarged proportion decrease 0, n = 48, 62 microm2; level 1, 35, microm2, 2, 22, 46 P 0.002). 10-year survival rates decreased (80% 64% 42% 0.004). rate 54 large (< or 36%) poorer than 51 small 80%, < 0.001). recognized as important predictor for prognosis Although not risk factor metastasis, 80% who developed metastasis had both expression. CONCLUSIONS: Detection carcinoma may reveal information

参考文章(29)
William B. Isaacs, Stephen B. Baylin, Nancy E. Davidson, Jeremy R. Graff, James G. Herman, Rena G. Lapidus, Paula M. Pitha, Rosa Xu, Hemi Chopra, David F. Jarrard, E-Cadherin Expression Is Silenced by DNA Hypermethylation in Human Breast and Prostate Carcinomas Cancer Research. ,vol. 55, pp. 5195- 5199 ,(1995)
A. Nagafuchi, M. Takeichi, Cell binding function of E-cadherin is regulated by the cytoplasmic domain. The EMBO Journal. ,vol. 7, pp. 3679- 3684 ,(1988) , 10.1002/J.1460-2075.1988.TB03249.X
Karl-Friedrich Becker, Ingrid Becker, Michael J. Atkinson, Jörg R. Siewert, Ulrike Reich, Hjalmar Nekarda, Heinz Höfler, E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Research. ,vol. 54, pp. 3845- 3852 ,(1994)
Parry Guilford, Justin Hopkins, James Harraway, Maybelle McLeod, Ngahiraka McLeod, Pauline Harawira, Huriana Taite, Robin Scoular, Andrew Miller, Anthony E. Reeve, E-cadherin germline mutations in familial gastric cancer Nature. ,vol. 392, pp. 402- 405 ,(1998) , 10.1038/32918
G. F. W. Scheumann, G. Brabant, H. Dralle, E. Pötter, R. Von Wasielewski, A. Georgii, A. Rhein, M. Werner, Immunohistochemical Detection of E-Cadherin in Differentiated Thyroid Carcinomas Correlates with Clinical Outcome Cancer Research. ,vol. 57, pp. 2501- 2507 ,(1997)
J Behrens, M M Mareel, F M Van Roy, W Birchmeier, Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. Journal of Cell Biology. ,vol. 108, pp. 2435- 2447 ,(1989) , 10.1083/JCB.108.6.2435
Osamu Kimura, Kazuo Kurayoshi, Kazuyoshi Hoshino, Akira Sugezawa, Masato Makino, Nobuaki Kaibara, Prophylactic portal infusion chemotherapy as adjuvant therapy for the prevention of metachronous liver metastasis in colorectal cancer Surgery Today. ,vol. 25, pp. 211- 216 ,(1995) , 10.1007/BF00311529
I. Taylor, D. Machin, M. Mullee, G. Trotter, T. Cooke, C. West, A randomized controlled trial of adjuvant portal vein cytotoxic perfusion in colorectal cancer. British Journal of Surgery. ,vol. 72, pp. 359- 363 ,(2005) , 10.1002/BJS.1800720509
C E Dukes, H J R Bussey, The spread of rectal cancer and its effect on prognosis. British Journal of Cancer. ,vol. 12, pp. 309- 320 ,(1958) , 10.1038/BJC.1958.37